Results
94
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
94 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IDGX.F | US$0.34 | 0% | n/a | US$220.9m | n/a | PE13.1x | E23.7% | n/a | ||
ONVV.F | AU$0.14 | 0% | n/a | AU$221.9m | n/a | PS13.9x | E69.2% | n/a | ||
INFU | US$6.75 | 4.5% | -30.0% | US$143.9m | US$13.88 | PE393.1x | E77.4% | n/a | ||
BRSY.F | ₪3.15 | 0% | n/a | ₪526.4m | n/a | PE232.2x | E70.7% | n/a | ||
BWAY | ₪8.07 | -0.4% | 99.8% | ₪526.4m | n/a | PE232.2x | E70.7% | n/a | ||
MYO | US$3.90 | 0.3% | 251.4% | US$117.9m | US$7.04 | PS5.6x | E69.8% | n/a | ||
RMTI | US$3.66 | -16.8% | 76.0% | US$113.6m | US$7.50 | PS1.2x | E169.8% | n/a | ||
NUTX | US$19.50 | -20.4% | -35.8% | US$98.8m | US$45.00 | PB1.6x | E125.7% | n/a | ||
PXMB.F | SEK 3.50 | 0% | n/a | SEK 1.0b | SEK 5.20 | PE42.7x | E57.2% | n/a | ||
SRTS | US$5.88 | 1.4% | 112.3% | US$96.4m | US$10.67 | PE14.5x | E20.8% | n/a | ||
XTNT | US$0.67 | -4.6% | -39.1% | US$92.9m | US$2.35 | PB2.1x | E70.3% | n/a | ||
TDMM.F | AU$0.36 | 0% | n/a | AU$136.6m | n/a | PS4.7x | E70.3% | n/a | ||
IPDQ.F | AU$0.048 | 0% | -58.3% | AU$117.3m | n/a | PS11.4x | E68.9% | n/a | ||
ECOR | US$6.75 | 4.5% | 11.2% | US$43.5m | US$23.10 | PS2x | E68.9% | n/a | ||
ICCM | US$0.62 | -2.4% | 15.7% | US$30.9m | US$3.22 | PS9.3x | E61.1% | n/a | ||
TLTF.F | CA$0.13 | -0.9% | -23.9% | CA$41.3m | n/a | PS44.8x | E71.9% | n/a | ||
MCRX.F | AU$0.03 | 0% | n/a | AU$40.7m | n/a | PS2.7x | E86.1% | n/a | ||
LFWD | US$3.15 | 0.6% | -40.8% | US$27.6m | US$10.75 | PS1.2x | E70.1% | n/a | ||
EKSO | US$1.20 | -0.8% | 63.7% | US$25.9m | US$6.25 | PS1.4x | E71.2% | n/a | ||
NXGL | US$2.59 | -5.5% | 22.2% | US$17.5m | US$6.00 | PS3.5x | E70.5% | n/a | ||
OTRK | US$2.63 | -16.1% | -79.7% | US$8.4m | US$45.00 | PB0.5x | E64.5% | n/a | ||
POAI | US$0.79 | -3.7% | -75.4% | US$5.2m | US$3.00 | PS3x | E72.4% | n/a |